June 18, 2013 9:32 PM ET

Biotechnology

Company Overview of Emerillon Therapeutics Inc.

Company Overview

Emerillon Therapeutics, Inc., a biotechnology company, engages in the discovery and development of genomics-based drugs for infectious diseases. The company, through its recombinant congenic strains (RCS) mouse platform technology, discovers and develops drugs for human complex diseases. Its RCS mouse platform focuses on identifying drug targets in the fields of pain, atherosclerosis, osteoporosis, and epilepsy. Emerillon Therapeutics also offers contract services, such as mutation detection using dHPLC, mouse genotyping, and speed congenesis. The company was founded in 2003 and is based in Montréal, Canada.

416 de Maisonneuve West

Suite 1000

Montréal, QC H3A 1L2

Canada

Founded in 2003

Phone:

514-985-0306

Fax:

514-985-0012

Key Executives for Emerillon Therapeutics Inc.

Chief Executive Officer
Director of Research and General Manager
Compensation as of Fiscal Year 2012.

Similar Private Companies By Industry

Company Name Region
Dragon Pharmaceutical Inc. Americas
Sherfam Inc. Americas
Virocell, Inc. Americas
ID Biomedical Corporation of Quebec Americas
Kerr Investment Holding Corp. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Emerillon Therapeutics Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.